Go Pro

Connor Murphy Analyst Performance

Analyst at BMO Capital Markets

Connor Murphy is a stock analyst at BMO Capital Markets focused in the computer and technology sector, covering 3 publicly traded companies. Over the past year, Connor Murphy has issued 4 stock ratings, including strong buy and buy recommendations. While full access to Connor Murphy's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Connor Murphy's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
5 Last 1 Years
Buy Recommendations
80.00% 4 Buy Ratings
Companies Covered
3 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy20.0%1 ratings
Buy60.0%3 ratings
Hold20.0%1 ratings
Sell0.0%0 ratings

Out of 5 total stock ratings issued by Connor Murphy at BMO Capital Markets, the majority (60.0%) have been Buy recommendations, followed by 20.0% Strong Buy and 20.0% Hold.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
100.0% of companies on NASDAQ
3 companies

Connor Murphy, an analyst at BMO Capital Markets, currently covers 3 companies listed on , with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Computer and Technology
2 companies
66.7%
Medical
1 company
33.3%

Connor Murphy of BMO Capital Markets specializes in stock coverage within the Computer and Technology sector, with additional focus on Medical companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
1 company
33.3%
SECURITY
1 company
33.3%
INTERNET SOFTWARE
1 company
33.3%

Connor Murphy's Ratings History at BMO Capital Markets

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
7/20/2026Initiated Coverage$16.77$36.00Outperform
Trevi Therapeutics, Inc. stock logo
TRVI
Trevi Therapeutics
7/20/2026Upgrade$18.18Strong-Buy
Zscaler, Inc. stock logo
ZS
Zscaler
11/26/2025Set Price Target$289.73$320.00Overweight
Zscaler, Inc. stock logo
ZS
Zscaler
11/25/2025Upgrade$251.97$320.00Overweight
Atlassian Corporation PLC stock logo
TEAM
Atlassian
7/16/2025Downgrade$187.69$211.00Equal Weight